Effects of male reproductive toxicants on gene expression in rat testes

Tamio Fukushima1, Toshinori Yamamoto, Rie Kikkawa

  • 1Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., Aichi.

Insights

Identifying novel genomic biomarkers for testicular toxicity is crucial for drug development. This study proposes three spermatogenesis-related genes as early indicators of testicular damage, detectable before pathological changes occur.

Area of Science:

  • Toxicology
  • Genomics
  • Reproductive Biology

Background:

  • Drug development requires predictive biomarkers for testicular toxicity.
  • Understanding male reproductive toxicant mechanisms is essential.
  • Current methods for detecting testicular toxicity can be slow.

Purpose of the Study:

  • To investigate the toxicity mechanisms of male reproductive toxicants.
  • To identify genomic biomarkers for rapid screening of testicular toxicity.
  • To evaluate the utility of cDNA microarray for early toxicity detection.

Main Methods:

  • Oral administration of four reproductive toxicants to male rats.
  • Gene expression profiling using cDNA microarray and real-time RT-PCR.
  • Histopathological examination of testicular tissues.

Main Results:

  • Differential gene expression profiles were observed, characterizing compound actions.
  • Three spermatogenesis-related genes (HSP70-2, IGFBP3, GSTP1) were consistently affected by all toxicants.
  • Gene expression changes were detectable within six hours, preceding histopathological findings.

Conclusions:

  • cDNA microarray is a valuable tool for assessing primary testicular toxicity.
  • Heat shock protein 70-2, insulin growth factor binding protein 3, and glutathione S transferase pi are proposed as potential testicular toxicity biomarkers.
  • Early detection of testicular toxicity via gene expression profiling can accelerate drug development.